Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jan 05, 2022 |
referred to health |
Feb 11, 2021 |
referred to health |
Senate Bill S4774
2021-2022 Legislative Session
Sponsored By
(D, WF) Senate District
Archive: Last Bill Status - In Senate Committee Health Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
co-Sponsors
(D, WF) 31st Senate District
2021-S4774 (ACTIVE) - Details
- See Assembly Version of this Bill:
- A6067
- Current Committee:
- Senate Health
- Law Section:
- Public Health Law
- Laws Affected:
- Amd §3333, Pub Health L
- Versions Introduced in 2019-2020 Legislative Session:
-
S6630
2021-S4774 (ACTIVE) - Sponsor Memo
BILL NUMBER: S4774 SPONSOR: REICHLIN-MELNICK TITLE OF BILL: An act to amend the public health law, in relation to labeling prescription bottles of opioids PURPOSE: This bill will require manufacturers and software companies that prepare labels for prescription drugs, which are approved by the state, to contain a warning regarding the addictive properties of opioid drugs. SUMMARY OF PROVISIONS: Section one amends subdivision 2 of section 3333 of the Public Health Law by adding paragraph (d), providing that a new warning must be added to the labels of prescription bottles containing opioid drugs. The warning will read: "Warning. This drug is highly addictive and may cause depression and overdose. Please consult your pharmacist or physician
2021-S4774 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 4774 2021-2022 Regular Sessions I N S E N A T E February 11, 2021 ___________ Introduced by Sen. REICHLIN-MELNICK -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to labeling prescription bottles of opioids THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Subdivision 2 of section 3333 of the public health law is amended by adding a new paragraph (d) to read as follows: (D) IN ADDITION TO THE OTHER REQUIREMENTS OF THIS SUBDIVISION, WHERE THE CONTROLLED SUBSTANCE BEING DISPENSED IS AN OPIOID, THERE SHALL BE AFFIXED TO THE CONTAINER A LABEL UPON WHICH IS INDELIBLY TYPED, PRINTED, OR OTHERWISE LEGIBLY WRITTEN "WARNING. THIS DRUG IS HIGHLY ADDICTIVE AND MAY CAUSE DEPRESSION AND OVERDOSE. PLEASE CONSULT YOUR PHARMACIST OR PHYSICIAN BEFORE USING." § 2. This act shall take effect on the ninetieth day after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD08314-01-1
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.